Stocks Health care IRWD
NASDAQ · Health careIronwood Pharmaceuticals Inc (IRWD)
Ironwood Pharmaceuticals Inc brought in $389.3M of revenue over the twelve months to June 30, 2026, up 26.2% from a year earlier. Net income was $129.9M, a net margin of 33.4%. Operating cash flow minus capital spending left $127M of free cash flow in fiscal 2025. At June 30, 2026 it held $79.1M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 6, 2026.
What Ironwood Pharmaceuticals Inc does
Ironwood Pharmaceuticals Inc is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker IRWD.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $296.2M | $24M | $0.15 | $127M |
| 2024 | $351.4M | $880K | $0.01 | $103.4M |
| 2023 | $442.7M | -$1B | -$6.45 | $183.2M |
| 2022 | $410.6M | $175.1M | $0.96 | $273.6M |
| 2021 | $413.8M | $528.4M | $3.21 | $261.6M |
| 2020 | $389.5M | $106.2M | $0.66 | $167M |
Latest SEC filings
What Ironwood Pharmaceuticals Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 7, 2026Passive stake (5% or more) SCHEDULE 13G
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026
- August 6, 2026
- July 28, 2026Passive stake changed SCHEDULE 13G/A
- June 18, 2026
- June 15, 2026Other event 8-K
- May 21, 2026
- May 15, 2026Passive stake changed SCHEDULE 13G/A
- May 14, 2026Passive stake changed SCHEDULE 13G/A
Questions about IRWD
What does Ironwood Pharmaceuticals Inc do?
Ironwood Pharmaceuticals Inc is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker IRWD.
Is Ironwood Pharmaceuticals Inc profitable?
Yes. Over the twelve months to June 30, 2026 it reported net income of $129.9M on revenue of $389.3M, a net margin of 33.4%.
How much revenue does Ironwood Pharmaceuticals Inc make?
Over the twelve months to June 30, 2026 Ironwood Pharmaceuticals Inc reported revenue of $389.3M. That is 26.2% more than a year earlier.
When did Ironwood Pharmaceuticals Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 6, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the planned insider sale from September 23, 2026.
Similar companies
Follow IRWD
Get an email when Ironwood Pharmaceuticals Inc files with the SEC: results, executive changes, material agreements and annual reports.
Follow IRWD: get an email when it filesWhere the numbers come from
Financial figures are the values Ironwood Pharmaceuticals Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.